title: Hemangiomas treated with propranolol: do the rewards outweigh the risks?
abstract: Recent reports of propranolol for the treatment of hemangiomas have led many physicians to question the best treatment strategy for children with vision-threatening hemangiomas. Although propranolol has potential side effects, including hypoglycemia and hypotension, early studies suggest it is more efficacious than systemic cortico steroids with a lower incidence of adverse side effects.
authors.forename: Kathryn M
authors.initials: KM
authors.lastname: Haider
authors.forename: Daniel E
authors.initials: DE
authors.lastname: Neely
authors.forename: David A
authors.initials: DA
authors.lastname: Plager
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D002648:Child; D006391:Hemangioma / Q000188:drug therapy*; D006801:Humans; D009918:Orbital Neoplasms / Q000188:drug therapy*; D011433:Propranolol / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000319:Adrenergic beta-Antagonists; D011433:Propranolol